Home » Topics » Cardiovascular, BioWorld Science

Cardiovascular, BioWorld Science
RSS

Sumitomo describes new compounds for cardiovascular disorders

July 21, 2000

Advances in gene therapy for preventing restenosis reported in Vancouver

July 21, 2000

Beneficial effects described at World Congress on Heart Failure for enrasentan in SHRSP-HSHF model

July 21, 2000

Added benefit of ET blockade and angiotensin receptor antagonism in CHF

July 20, 2000

SM-20550 provides protection against I/R-induced skeletal muscle injury

July 20, 2000

Role of vasopressin and vasopressin antagonists in heart failure reviewed at recent congress

July 20, 2000

Dual ETA/ETB receptor antagonists claimed by Kowa as cardiovascular therapeutics

July 19, 2000

BMS to conduct new study of omapatrilat as treatment for hypertension

July 18, 2000

Potent benzomaltoside-based inhibitors of smooth muscle cell proliferation

July 18, 2000

CVT-2759 as an alternative to adenosine A1 receptor full agonists

July 18, 2000

Popular Stories

Today's news in brief
BioWorld
BioWorld briefs for June 29, 2026.
ENCALS 2026: From genetics to advancing strategies against ALS
BioWorld Science
Amyotrophic lateral sclerosis (ALS)-associated genes provide direct therapeutic targets and reveal pathways that can be used to develop treatments that counteract...
Next wave of BCI firms builds on pioneers to tackle challenges
BioWorld
With the pace of neurotechnology development accelerating, a wave of brain-computer interface (BCI) companies is emerging on the heels of the pioneers. In the...
Boehringer Ingelheim identifies new mGlu3 receptor agonists
BioWorld Science
Boehringer Ingelheim Pharma GmbH & Co. KG and Vanderbilt University have discovered new dihydrobenzoxazine compounds acting as metabotropic glutamate mGlu3...
GT-02897 exerts efficacy in preclinical multiple myeloma
BioWorld Science
Investigators from the Karl Landsteiner University aimed to evaluate the therapeutic potential of a novel CDK9 inhibitor/degrader, GT-02897, for the potential...